Targeting SRSF1 improves cancer immunotherapy by dually acting on CD8+T and tumor cells

Gui‐Qi Zhu(Ministry of Education of the People's Republic of China), Jia Fan(Nanjing Tech University)

Signal Transduction and Targeted Therapy

January 21, 2025

10.1038/s41392-024-02118-2

Cited by 14

Related Papers

Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma

|Cell|2019|1.2k

Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma

|Nature|2019|982

Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)

|Liver Cancer|2020|828

Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma

|Nature Metabolism|2023|540

Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma

|Cancer Cell|2021|408